Weiguo Qing
Corporate Officer/Principal bij Hutchison MediPharma Ltd.
Actieve functies van Weiguo Qing
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01-01-2008 | - |
Loopbaan van Weiguo Qing
Eerdere bekende functies van Weiguo Qing
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Roche Corp. | Corporate Officer/Principal | - | - |
Opleiding van Weiguo Qing
The University of Texas at Austin | Doctorate Degree |
Institute of Materia Medica | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
China | 3 |
Operationeel
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Roche Corp. |
- Beurs
- Insiders
- Weiguo Qing
- Ervaring